Japan Intellectual Property Rights: GROUND STRENGTH CALCULATION DEVICE, GROUND STRENGTH CALCULATION METHOD, AND GROUND STRENGTH CALCULATION PROGRAM

Japan, Feb. 18 -- KFC LTD,ADVANCED CONSTRUCTION TECHNOLOGY CENTER has got intellectual property rights for 'GROUND STRENGTH CALCULATION DEVICE, GROUND STRENGTH CALCULATION METHOD, AND GROUND STRENGTH CALCULATION PROGRAM.' Other related details are as follows: Application Number: JP,2022-139137 Category (FI): E02D1/02,E02D7/02 Stage: Grant (IP right granted following substantive examination.) Filing Date: Sept. 1, 2022 Publication Date: March 13, 2024 The original document can be viewed at:...


Clinical Trial: A prospective observational study to clarify risk factors for progression of frailty in elderly patients with heart failure (Japan)

Tokyo, Feb. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060698) titled 'A prospective observational study to clarify risk factors for progression of frailty in elderly patients with heart failure' on Feb. 18. Study Type: Observational Primary Sponsor: Institute - Kyoto Medical Center, Division of translational research Condition: Condition - Heart failure Classification by malignancy - Others Genomic information - NO Objective: Narrative ...


Clinical Trial: A Randomized Controlled trial of a Psychoeducational Web Application for Social Anxiety in Social Situations (Japan)

Tokyo, Feb. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060669) titled 'Randomized Controlled Trial of a Psychoeducational Web Application for Social Anxiety in Social Situations' on Feb. 18. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -no one is blinded Control - No treatment Primary Sponsor: Institute - Department of Cognitive Behavioral Physiology ,Chiba University Graduate...


Clinical Trial: Molecular Pathological Analysis of Biopsy and Autopsy Specimens from Patients Who Developed Adverse Events following COVID-19 Infection and/or COVID-19 Vaccination (Japan)

Tokyo, Feb. 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060702) titled 'Molecular Pathological Analysis of Biopsy and Autopsy Specimens from Patients Who Developed Adverse Events following COVID-19 Infection and/or COVID-19 Vaccination' on Feb. 18. Study Type: Observational Primary Sponsor: Institute - Japanese Society for Vaccine-related Complications Condition: Condition - Adverse events following COVID-19 infection and/or COVID-19 vacci...


Clinical Trial: Observational study about the relationship between intestinal flora,intestinal barrier and kidney function in the chronic kidney disease patients (Japan)

Tokyo, Feb. 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060704) titled 'Observational study about the relationship between intestinal flora,intestinal barrier and kidney function in the chronic kidney disease patients' on Feb. 18. Study Type: Observational Primary Sponsor: Institute - Kyoto University Condition: Condition - chronic kidney disease Classification by malignancy - Others Genomic information - NO Objective: Narrative objective...


Clinical Trial: A multicenter prospective comparative study of 19G Fine Needle Aspiration (FNA) and Fine Needle Biopsy (FNB) needles for mediastinal and intraperitoneal lymphadenopathy (Japan)

Tokyo, Feb. 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060703) titled 'A multicenter prospective comparative study of 19G Fine Needle Aspiration (FNA) and Fine Needle Biopsy (FNB) needles for mediastinal and intraperitoneal lymphadenopathy' on Feb. 18. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Single blind -participants are blinded Control - Active Primary Sponsor: Institute - O...


How Humour-Led Content Helped True Diamond Stand Out in India's Cluttered Jewellery Market

India, Feb. 17 -- True Diamond, a jewelry brand that has got millions of Indians hooked onto their content and have used this approach to break away from the stereotype of jewellery marketing.They recently went on Shark Tank season 5 but didn't get the deal, but won the internet instead.When True Diamond, a lab-grown diamond jewellery brand known for its honest, no-frills voice, appeared on Shark Tank India, it found itself pitched directly against Emory, another lab-grown diamond brand. Emory w...


"Naan Ketkum Varam Nee" Strengthens Tamil Indie Presence

India, Feb. 17 -- Chennai: Tamil indie music continues to scale new heights as "Naan Ketkum Varam Nee" by Deri Lorus surpasses 250K+ views on YouTube released on Cineulagam Originals and over 150K streams on YouTube Music, marking a significant milestone in its growing success story.The romantic melodic single has also gained impressive traction across major digital streaming platforms including Spotify, Apple Music, JioSaavn, and YouTube Music, where it has consistently charted among top-perfor...


LegalEdge Explains Why MH CET Law Is Misjudged by Most Aspirants

India, Feb. 17 -- For CET-focused law aspirants, the real challenge isn't "tough questions"-it's an underestimated exam with predictable traps.A striking pattern is emerging among Maharashtra's law aspirants: many treat MH CET Law as a "safe" exam, only to be surprised on result day. Mentors and exam observers say the test is routinely misjudged-not because it is impossibly difficult, but because it punishes casual preparation, weak reading discipline, and poor section-balancing. The exam is con...


Microcap Company, Kabra Drugs Limited Reports Strong Q3FY26 Results and Bold Expansion Moves

India, Feb. 17 -- Chennai, India, February 17, 2026 - PAT rose 578% compared to last year as Kabra Drugs Limited (BSE: 524322), a fast‑emerging microcap company, announced its unaudited financial results for the quarter ended December 31, 2025, on February 13, 2026, alongside a series of strategic initiatives approved earlier on January 1, 2026. Together, these milestones underscore the Company's turnaround momentum, its diversification into high‑growth industries, and the strong inv...